⏰ Last chance! Join Premium for $20/month before it increases to $49/month.
US Stocks
SMMT

Summit Therapeutics Inc. Common Stock

$17.32
-0.09 (-0.49%)

Volume:

13.387K ($231.86K)
#366 Volume#435 Dollar Volume

Market Capitalization:

$13.82B
#457 Market Cap

Live Price

Live Volume

Chart Volume 0
Volume 0
5 sec

Summit Therapeutics Market Segments

Premarket

-0.01(-0.06%)
Open$17.33
Close$17.32
Low$17.26
Low Change-0.07 (-0.40%)
High$17.54
High Change+0.21 (+1.21%)
Range$0.28
Volume13.387K
Dollar Volume$231.86K

Overnight

-0.05(-0.29%)
Open$17.34
Close$17.29
Low$17.28
Low Change-0.06 (-0.35%)
High$17.40
High Change+0.06 (+0.35%)
Range$0.12
Volume3.027K
Dollar Volume$52.34K

After Hours Yesterday

-0.05(-0.29%)
Open$17.40
Close$17.35
Low$17.29
Low Change-0.11 (-0.63%)
High$18.40
High Change+1.00 (+5.75%)
Range$1.11
Volume517.354K
Dollar Volume$8.98M

Regular Trading Hours Yesterday

-0.76(-4.16%)
Open$18.16
Close$17.41
Low$17.11
Low Change-1.05 (-5.78%)
High$18.47
High Change+0.31 (+1.71%)
Range$1.36
Volume5.164M
Dollar Volume$89.88M

Premarket Yesterday

-0.13(-0.71%)
Open$18.30
Close$18.17
Low$18.01
Low Change-0.29 (-1.58%)
High$18.51
High Change+0.21 (+1.14%)
Range$0.50
Volume41.039K
Dollar Volume$745.68K

Summit Therapeutics Top Trades

Summit Therapeutics's top trade so far today returned +1.21%, while the top short trade returned -1.25%.

Unlock the exact entry and exit times, prices, durations, and more top-performing trades with Finsuba Premium. Learn more >>>

Summit Therapeutics Moving Averages

5 Day Moving Average (SMA5)$17.59
10 Day Moving Average (SMA10)$16.87
20 Day Moving Average (SMA20)$15.11
50 Day Moving Average (SMA50)$14.55
100 Day Moving Average (SMA100)$15.51
200 Day Moving Average (SMA200)$16.43

Summit Therapeutics Statistics

Average Volume (30 Days)5.73M
P/E Ratio (Current)-17.21
EPS (Current)-$1.07
Dividend Yield0.00%
Free Cash Flow-$459.82M
Cash Ratio4.05
Current Ratio6.96
Quick Ratio6.96
Debt to Equity0.00
Enterprise Value$14.28B
EV to EBITDA-16.32
EV to Sales—
Price to Book23.33
Price to Cash Flow—
Price to Free Cash Flow—
Price to Sales—
Return on Assets-1.14%
Return on Equity-1.36%

Summit Therapeutics Stock Splits

There have been no stock splits for Summit Therapeutics (SMMT).

Summit Therapeutics Dividends

There have been no dividends for Summit Therapeutics (SMMT).